Fairvalue-Calculator Fairvalue-Calculator

Sirio Pharma Co (300791) Fair Value & Analysis

Consumer Defensive · CN · Market cap 5.2B CNY

Price¥16.84
Fair Value¥11.69
Upside-30.6%
Quality95/100
Evidence: High Range ¥7.43 – ¥15.85

Analysis

Sirio Pharma Co (300791) currently trades at ¥16.84, while our model-based Fair Value estimate is ¥11.69 — implying the stock looks roughly 30.6% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.

Open the full interactive analysis →

Similar stocks

Nestlé S.A (NSRGF) -33% Foshan Haitian Flavouring and Food Company (603288) -28% Nestlé India Limited (NESTLEIND) -75% Grupo Bimbo, S.A. (BIMBOA) -21% Uni-President Enterprises Corp (1216) -27% Britannia Industries Limited (BRITANNIA) -62%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.